Continuous Glucose Monitors for Diabetic Dogs and Cats
Quick answer: Pet continuous glucose monitors (CGMs) aren't something you buy and strap on yourself — a vet applies a small sensor to a shaved patch of skin, and it reports glucose readings every few minutes to a phone app for up to about two weeks, replacing repeated blood draws for a diabetic dog or cat. Most current use is the human FreeStyle Libre applied off-label (not officially supported by Abbott for animals, sensors often detach before their rated 14 days, roughly $100-150+/month in sensor costs). A purpose-built alternative, GluCurve Pet CGM, relaunched in Canada in May 2026 and had targeted a Q2 2026 US relaunch too, but as of late September 2026 that US launch isn't independently confirmed yet. Either way, this is a vet-managed tool for a diagnosed diabetic pet, not a general wellness gadget.
This is a genuinely different category from the wearables and health monitors covered elsewhere on this site: a continuous glucose monitor (CGM) for a diabetic dog or cat is applied by a veterinarian, not ordered and set up by an owner, and it exists to solve one specific clinical problem — getting a full picture of a diabetic pet’s blood sugar without repeated blood draws or a stressful, stay-all-day in-clinic glucose curve.
Why this exists: the problem with the old way
Managing a diabetic pet’s insulin dose has traditionally meant an in-clinic “glucose curve” — checking blood sugar every couple of hours over most of a day, which usually means hospitalizing the pet for the day and multiple needle sticks. Veterinary sources note a real confound with this method too: the stress of being at the clinic itself can raise a cat’s blood sugar (stress hyperglycemia), skewing the very numbers the vet is trying to read. A CGM sensor worn at home, in a pet’s normal environment, over multiple days gives a more complete and less stress-distorted picture, without repeated needle sticks.
Two real paths: off-label human CGM vs. purpose-built veterinary CGM
Off-label use of a human CGM (Abbott’s FreeStyle Libre) is the most common option in practice today. A vet applies the sensor to a shaved patch of skin, usually on the upper back or flank, and it’s rated to report glucose readings for up to 14 days, read via the free LibreLink phone app or an optional dedicated reader. It’s genuinely off-label: Abbott doesn’t validate or officially support FreeStyle Libre for animal use, its support line won’t field animal-use questions, and it won’t replace a sensor that fails or detaches early on a pet — a real, documented limitation, not a hypothetical one. In practice, vets report sensors often come loose before their rated 14 days given a pet’s fur, movement, and scratching, so budget for more frequent replacement than the label duration implies.
Purpose-built veterinary CGM (GluCurve Pet CGM, from ALR Technologies) is a monitoring system designed specifically for cats and dogs rather than adapted from a human product, sold through veterinary clinics rather than directly to pet owners. It reports readings roughly every three minutes for up to 14 days, feeding both a pet-owner-facing app and a separate veterinary web portal the vet uses to adjust insulin dosing. It had gone off the market and is relaunching in stages: ALR Technologies confirmed GluCurve went on sale in Canada in May 2026, on schedule with its original plan. The company’s own US target was the second quarter of 2026, but as of this check (late September 2026) no independent source — trade press, a retailer, or ALR’s own announcements — confirms the US relaunch has actually happened yet, so treat “available in the US” as still unconfirmed rather than assume the original target date held. One real, relevant development since the original target was set: ALR Technologies announced in mid-2026 that it’s acquiring outside CGM manufacturing operations (in Singapore and Shenzhen) specifically to scale production capacity toward 300,000 units/month for GluCurve and future CGM products — a sign of continued investment in the product, though the acquisition itself is still an active, uncompleted process, which may be part of why a firm US on-sale date hasn’t been confirmed yet. A separate company, Adapet Medical, also sells a pet-specific CGM sensor rated for up to 14 days of continuous glucose data. Because these are distributed through veterinary practices rather than listed with a public retail price, expect the practice to set pricing rather than finding one published number.
What it actually costs
For the off-label FreeStyle Libre route, expect roughly $40-75 per sensor and an optional $60-90 reader (skippable if you’re using the free LibreLink app on a phone). Since sensors on pets commonly detach before their full 14-day rating, realistic ongoing cost lands around $100-150+ per month for an actively monitored pet — closer to buying 2-3 sensors a month than one. Purpose-built systems like GluCurve are priced at the clinic level rather than published as a flat retail figure, since the clinic applies the sensor and manages the data as part of ongoing diabetes care, not as a standalone purchase.
A real, honest caveat on accuracy
These sensors, FreeStyle Libre in particular, were engineered and clinically validated for human physiology, not canine or feline. Veterinary researchers are actively studying how well that translates — Cornell’s veterinary college has run a dedicated accuracy study of the FreeStyle Libre 3 specifically in diabetic cats, and published case series and reviews in veterinary journals discuss both the real benefits and the open questions around sensor accuracy and reliability in animals. This isn’t a reason to avoid the technology, which veterinary sources broadly describe as a genuine improvement over stress-inducing in-clinic blood draws, but it’s worth knowing this is still maturing science in animals specifically, not a fully solved, decades-validated fit the way it is in human medicine.
How this differs from what else this site covers
This is a distinct category from our activity and vital-sign monitor guide: PetPace and FitBark are owner-managed wearables for general wellness trends in any pet, while a CGM is a vet-applied, clinically narrower tool specifically for a pet already diagnosed with diabetes. It’s also a different product from genetic health-screening DNA tests, which flag inherited risk markers rather than measure real-time blood chemistry. If your vet is managing insulin dosing alongside CGM data, see our medication reminder app guide for keeping the actual insulin schedule on track, and our vet telehealth guide for platforms some owners use to review CGM trends with a vet between in-person visits.
Verified 2026-09-29: GluCurve’s Canada relaunch is now confirmed complete (on sale since May 2026, per ALR Technologies’ own announcement) — this article originally described it only as “planned.” The originally-targeted Q2 2026 US relaunch date has passed without an independently confirmed US launch as of this check; updated the article to reflect that rather than continue stating the target date as if it had been met.
Bottom line
A pet CGM isn’t a gadget to shop for on your own — it’s a vet-managed tool for a pet already diagnosed with diabetes, and the practical choice is less “which brand” and more “off-label human FreeStyle Libre, applied by your vet, at roughly $100-150+/month in sensor costs” versus “a purpose-built system like GluCurve or Adapet, sold and priced through the clinic.” Either way, ask your vet directly about sensor retention, replacement policy, and realistic monthly cost before assuming the rated 14-day duration is what you’ll actually get.
Frequently asked questions
Can I buy a pet CGM myself and put it on my dog or cat?
No — this isn't a consumer wearable like a GPS collar or activity tracker you order and set up yourself. A veterinarian applies the sensor (typically to a shaved patch of skin on the upper back or flank) and manages the data through a clinical portal alongside whatever app you use at home. It's a prescription-adjacent tool for a pet already diagnosed with diabetes, not something to try preemptively.
Is it safe to use a human glucose monitor like FreeStyle Libre on a pet?
It's widely used this way in veterinary practice and covered in AAHA's own diabetes management guidelines, but it's genuinely off-label — Abbott doesn't officially support or validate FreeStyle Libre for animal use, won't answer questions about animal use through its support line, and won't replace a sensor that detaches early on a pet. Vets report it works well in practice and it's far more affordable than purpose-built veterinary alternatives, but go in knowing there's no manufacturer backing if something goes wrong with the hardware itself.
How much does continuous glucose monitoring actually cost for a pet?
For the off-label FreeStyle Libre route: individual sensors typically run $40-75 each from veterinary sourcing, rated for up to 14 days but commonly falling off closer to 6-10 days on an active pet, plus an optional $60-90 reader (or the free LibreLink phone app in place of a reader). Realistic ongoing cost lands around $100-150+ per month once you account for more frequent sensor changes than the rated duration. Purpose-built veterinary systems like GluCurve are sold through the vet clinic rather than directly to owners, so pricing is set at the practice level rather than published as a flat retail number.
How is this different from a pet activity or vital-sign monitor like PetPace or FitBark?
Those are wearables you buy and manage yourself, continuously tracking general trends (steps, sleep, and for PetPace, heart rate/respiration/temperature) for any pet. A glucose monitor is narrower and more clinical: it's applied by a vet, specifically for a pet already diagnosed with diabetes, and exists to replace the stress and repeated blood draws of an in-clinic glucose curve with continuous data the vet uses to adjust insulin dosing. See our activity and vital-sign monitor guide if what you actually want is general wellness tracking rather than diabetes management.